Stay updated on Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial

Sign up to get notified when there's something new on the Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The study record NCT03873818 on ClinicalTrials.gov was updated with a new last update date (2025-04-27) and current enrollment status.
    Difference
    0.4%
    Check dated 2025-11-03T12:32:43.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    35 days ago
    Change Detected
    Summary
    Update includes a critical operating status notice and a new software version (v3.2.0), indicating updated deployment status and the presence of temporary funding-related notices; the previous version tag (v3.1.0) was removed.
    Difference
    3%
    Check dated 2025-10-05T16:43:22.000Z thumbnail image
  4. Check
    43 days ago
    Change Detected
    Summary
    Significant expansion of immune-related terminology and an explicit version upgrade to v3.1.0. Older version v3.0.2 is removed.
    Difference
    0.9%
    Check dated 2025-09-28T09:52:20.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2 (replacing v3.0.1); the 'Back to Top' element was removed as a minor UI change.
    Difference
    0.2%
    Check dated 2025-09-14T00:12:07.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.2%
    Check dated 2025-09-06T21:04:03.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The web page has been updated to include a new facility name and location, along with additional medical topics related to brain tumors and skin diseases. Notably, the previous version's references to certain antineoplastic agents and specific melanoma topics have been removed.
    Difference
    3%
    Check dated 2025-08-30T15:32:30.000Z thumbnail image

Stay in the know with updates to Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial page.